Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 27, 2018
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST TrialsGreg Fulcher, Roopa Mehta, Edmond G Fita, et al.
Diabetes Care|March 6, 2014
Predictive and explanatory factors of change in HbA1c in a 24-week observational study of 66,726 people with type 2 diabetes starting insulin analogsPhilip D Home, Chunduo Shen, Mohammad I Hasan, et al.
Obstetrics and Gynecology International|June 12, 2012
Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during PregnancyJacques Lepercq, Jay Lin, Gillian C Hall, et al.
Diabetes, Obesity & Metabolism|June 30, 2017
Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)Philip D Home, Richard M Bergenstal, Geremia B Bolli, et al.
Diabetes Care|June 19, 2015
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)Philip D Home, Richard M Bergenstal, Geremia B Bolli, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0David R Owens, Wolfgang Landgraf, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|October 30, 2022
Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristicsPhilip D Home, Rory J McCrimmon, Julio Rosenstock, et al.
Advances in Nutrition (Bethesda, Md.)|January 19, 2017
Setting the Lipid Component of the Diet: A Work in ProcessFabiola M Del Razo Olvera, Marco A Melgarejo Hernández, Roopa Mehta, et al.
Diabetes Care|April 25, 2009
Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter studyGeremia B Bolli, David Kerr, Reena Thomas, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 11, 2014
Innovative models for the empowerment of patients with type 2 diabetes: the CAIPaDi programSergio Hernandez-Jimenez, Cristina Garcia-Ulloa, Roopa Mehta, et al.
Pageof 15